Vladonix Dosage Calculator
Vladonix is a natural thymus peptide bioregulator developed by Professor Vladimir Khavinson at the St.
10mcg · Daily
Summary: Add 0mL BAC water to your 20mg vial. Draw to < 0.1 units on a U-100 syringe for a 10mcg dose. This vial will last 0 doses.
Cycle Planner
Vladonix Pharmacokinetics
Vladonix Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 10mg | Daily |
| Moderate | 20mg | 2x Daily |
| Aggressive | 20mg | 3x Daily |
Note: Thymus peptide bioregulator from the Khavinson line. Contains peptide complex A-6 derived from calf thymus. Standard protocol is 1-2 capsules daily for 30 days, repeated every 3-6 months. Oral capsule — no reconstitution needed.
About Vladonix
Vladonix is a natural thymus peptide bioregulator developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It contains peptide complex A-6, a mixture of low-molecular-weight peptides (under 10 kDa) extracted from the thymus glands of young calves. The product targets thymic tissue to support T-cell maturation and restore age-related immune decline. In a clinical study of 42 patients aged 34-65, Vladonix normalized impaired immune parameters in 78% of cases. The strongest effects were seen in T-lymphocyte subpopulations — CD3+ and CD4+ counts increased reliably, and the CD4+/CD8+ ratio returned to normal ranges. B-cell parameters showed more modest changes. Vladonix isn't a single defined peptide like Thymosin Alpha 1. It's a complex extract containing multiple short peptides that are thought to interact with DNA promoter regions in immune cells, influencing gene expression tied to T-cell differentiation and cytokine balance. This mechanism is consistent with Khavinson's broader bioregulation theory, where tissue-specific peptides act as epigenetic modulators. The product has been used in Russian clinical practice alongside other Khavinson bioregulators for over two decades. It's taken orally as capsules, doesn't require injection, and has shown no reported side effects or drug dependence in clinical observations. Evidence remains limited to Russian and Eastern European studies, and it hasn't undergone Western regulatory review.